Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DIEXF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NSD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANAPC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRMS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KDM3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETNK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929897 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C22orf42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAMP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BUD13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2orf82 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on